BUSINESS● LOWAug 12 · Aug 12, 2026, 11:29 AM
Unicycive Therapeutics GAAP EPS of -$0.06 beats by $0.27
Seeking Alpha Tech
Unicycive Therapeutics reported a GAAP EPS of -$0.06, which surpassed expectations by $0.27. This indicates the company's financial performance relative to analyst predictions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS32m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech